IPO
FILING
Transkaryotic
Therapies
Inc
WASHINGTON
Company
Name
Transkaryotic
Therapies
Inc
Nasdaq
Stock
symbol
TKTX
Estimated
price
range
shr
Total
shares
offered
million
Shrs
offered
company
million
Shrs
outstanding
ipo
Lead
Underwriter
Morgan
Stanley
Co
Inc
Underwriters
over-allotment
shrs
Shares
purchased
Hoechst
Marion
Roussel
Inc
Business
developed
two
proprietary
technology
platforms
gene
activation
gene
therapy
Use
Proceeds
Research
preclinical
clinical
product
development
general
corporate
purposes
Financial
Data
000s
Revenue
Net
Income
loss
